SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nuvelo (Nasdaq: NUVO) -- Ignore unavailable to you. Want to Upgrade?

To: DJ who wrote (99)2/2/2000 12:07:00 PM
From: equityanalyst  Respond to of 286
 
DJ - Yeah, this one looks like a real keeper. Buy it, put it away, come back in 10-15 years and you'll probably have a long-term gain on your investment equivalent to (hopefully better than) Microsoft, Berkshire Hathaway, QUALCOMM, etc. I've been in the investment business full time for the past 32 years, and I can't think of many other companies with prospects as attractive as HYSQ.

Best of Luck,
ea



To: DJ who wrote (99)2/2/2000 5:11:00 PM
From: Tom Hua  Read Replies (2) | Respond to of 286
 
When I read this morning's WSJ, I immediately
bought some HYSQ. This is going to be exciting.

DJ, exciting for sure. I shorted near the close at 55 after CNBC mentioned the stock. While the news is good, it doesn't deserve a doubling of the market cap.

Regards,

Tom


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News